A major goal of Texas Biologics is to strengthen and expand biomedical translational research at UT Austin. One mechanism to achieve this goal is to provide financial support for projects in biologics discovery and development. We launched the TXBio Pilot Grant Program to foster research across campus.
Current Funding Opportunities
The 2026 TXBio Pilot Grant competition is now closed.
We anticipate holding yearly or bi-yearly grant programs. More opportunities will be posted here as available.
For additional funding opportunities, or to leverage your TXBio Pilot Grant funding, see UT's Internal Funding Opportunities.
2026 Pilot Grant Awardees
Development and Mechanistic Assessment of an IL-25/CTLA-4 bispecific antibody to improve the therapeutic index of anti-CTLA-4 therapy in immune checkpoint inhibition-responsive cancers
- Mark Badeaux, Ph.D., Cockrell School of Engineering
- Annalee Nguyen, Ph.D., Cockrell School of Engineering
An allergen delivery system for immunotherapy of food allergy
- Zhengrong Cui, Ph.D., Pharmacy
- Laura Suggs, Ph.D., Cockrell School of Engineering
- Robert O Williams III, Ph.D., Pharmacy
Oral delivery of biological therapies through probiotic encoded circular RNA
- Bryan Davies, Ph.D., College of Natural Sciences
- Andrew Ellington, Ph.D., College of Natural Sciences
Developing a stockpile-ready pan-filovirus vaccine
- Qian Yin, Ph.D., Cockrell School of Engineering
- Zhengrong Cui, Ph.D., Pharmacy
